rdf:type |
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0205217,
umls-concept:C0332307,
umls-concept:C0392756,
umls-concept:C0681850,
umls-concept:C1336630,
umls-concept:C1423062,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2936350
|
pubmed:issue |
10
|
pubmed:dateCreated |
2009-10-1
|
pubmed:abstractText |
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified tissue inhibitor of metalloproteinase 3 (TIMP3), the endogenous inhibitor of A disintegrin and metalloprotease domain 17 (ADAM17) and other matrix metalloproteinases (MMPs), as a gene modifier for insulin resistance and vascular inflammation in mice. We tested its association with atherosclerosis in subjects with type 2 diabetes and identified Sirtuin 1 (SirT1) as a major regulator of TIMP3 expression.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1939-327X
|
pubmed:author |
pubmed-author:CardelliniMarinaM,
pubmed-author:CasagrandeVivianaV,
pubmed-author:FedericiMassimoM,
pubmed-author:FolliFrancoF,
pubmed-author:IppolitiArnaldoA,
pubmed-author:LauroRenatoR,
pubmed-author:MarinoAriannaA,
pubmed-author:MartelliEugenioE,
pubmed-author:MaurielloAlessandroA,
pubmed-author:MenghiniRossellaR,
pubmed-author:PorzioOttaviaO,
pubmed-author:RizzaStefanoS,
pubmed-author:SoliniAnnaA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2396-401
|
pubmed:dateRevised |
2010-10-4
|
pubmed:meshHeading |
pubmed-meshheading:19581416-ADAM Proteins,
pubmed-meshheading:19581416-Animals,
pubmed-meshheading:19581416-Atherosclerosis,
pubmed-meshheading:19581416-Carotid Arteries,
pubmed-meshheading:19581416-Carotid Artery Diseases,
pubmed-meshheading:19581416-Diabetes Mellitus, Type 2,
pubmed-meshheading:19581416-Humans,
pubmed-meshheading:19581416-Matrix Metalloproteinase 9,
pubmed-meshheading:19581416-Mice,
pubmed-meshheading:19581416-Reference Values,
pubmed-meshheading:19581416-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19581416-Sirtuin 1,
pubmed-meshheading:19581416-Sirtuins,
pubmed-meshheading:19581416-Tissue Inhibitor of Metalloproteinase-3
|
pubmed:year |
2009
|
pubmed:articleTitle |
TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.
|
pubmed:affiliation |
Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|